Illuminare Biotechnologies
Princeton
About Illuminare Biotechnologies
Illuminare Biotechnologies is a biotechnology company operating intended to reduce nerve damage risk during surgery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Last round: Series Unknown (Aug 2017)
- Website: illuminarebio.com
- Phone: 6094971282
Industries & Categories
Biotechnology, Health Care, Medical Device
Canonical: https://fsome.com/organization/illuminare-biotechnologies-103980 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.